BR9809279A - Procedimento para produção de uma fração de blocos g e/ou blocos m a partir de alginato - Google Patents

Procedimento para produção de uma fração de blocos g e/ou blocos m a partir de alginato

Info

Publication number
BR9809279A
BR9809279A BR9809279-0A BR9809279A BR9809279A BR 9809279 A BR9809279 A BR 9809279A BR 9809279 A BR9809279 A BR 9809279A BR 9809279 A BR9809279 A BR 9809279A
Authority
BR
Brazil
Prior art keywords
blocks
alginate
fraction
procedure
block
Prior art date
Application number
BR9809279-0A
Other languages
English (en)
Inventor
Merethe Kamfjord Simensen
Kurt Draget
Olaf Smidsroed
Finn Hjelland
Original Assignee
Fmc Biopolymer As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Biopolymer As filed Critical Fmc Biopolymer As
Publication of BR9809279A publication Critical patent/BR9809279A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F10/00—Homopolymers and copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

"PROCEDIMENTO PARA A PRODUçãO DE UMA FRAçãO DE BLOCOS G E/OU BLOCOS M A PARTIR DE ALGINATO". Um novo procedimento para a produção de frações de blocos a partir de alginato, principalmente, alginato de bloco G ou alginato de bloco M, pela liberação fracionada seletiva da fração de bloco M da fase sólida. Frações de bloco MG também podem ser isoladas.
BR9809279-0A 1997-05-09 1998-05-08 Procedimento para produção de uma fração de blocos g e/ou blocos m a partir de alginato BR9809279A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO19972136A NO305033B1 (no) 1997-05-09 1997-05-09 Fremgangsmate for fremstilling av uronsyreblokker fra alginat
PCT/NO1998/000142 WO1998051710A1 (en) 1997-05-09 1998-05-08 Procedure for producing uronic acid blocks from alginate

Publications (1)

Publication Number Publication Date
BR9809279A true BR9809279A (pt) 2000-10-03

Family

ID=19900705

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809279-0A BR9809279A (pt) 1997-05-09 1998-05-08 Procedimento para produção de uma fração de blocos g e/ou blocos m a partir de alginato

Country Status (11)

Country Link
US (1) US6121441A (pt)
EP (1) EP0980391B1 (pt)
JP (1) JP4454700B2 (pt)
CN (1) CN1090193C (pt)
AT (1) ATE230763T1 (pt)
AU (1) AU737398B2 (pt)
BR (1) BR9809279A (pt)
CA (1) CA2289710C (pt)
DE (1) DE69810609T2 (pt)
NO (1) NO305033B1 (pt)
WO (1) WO1998051710A1 (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7434200A (en) 1999-09-23 2001-04-24 Reckitt Benckiser (Uk) Limited Method for combating hard water and scale by using algins
KR100501584B1 (ko) 2000-02-03 2005-07-18 (주)케이비피 저분자 폴리만유로네이트의 제조방법, 혈청지질개선제로서의 이의 신규 용도 및 이를 함유하는 기능성식품 및 건강 보조 식품
NO320671B1 (no) * 2001-11-30 2006-01-16 Fmc Biopolymer As Fremgangsmate for a stimulere vektokning i fisk.
NO326145B1 (no) * 2001-11-30 2008-10-06 Fmc Biopolymer As Fremgangsmate for a stimulere vektokning hos pattedyr, fugler og krypdyr.
NO324131B1 (no) * 2001-11-30 2007-09-03 Fmc Biopolymer As Fremgangsmate for fremstilling av alginat som har et hoyt mannuronsyre-innhold
JP2005145885A (ja) * 2003-11-14 2005-06-09 Japan Science & Technology Agency アルギン酸オリゴマーからなる免疫機構賦活剤
CA2581330A1 (en) * 2004-09-21 2006-03-30 The Brigham And Women's Hospital, Inc. Methods and compositions relating to mannuronic acid specific binding peptides
CA2583373C (en) * 2004-10-12 2013-09-03 Fmc Biopolymer As Self-gelling alginate systems and uses thereof
PL1714605T3 (pl) 2005-04-21 2011-11-30 Reckitt Benckiser Uk Ltd Urządzenie i sposób
GB2430881B (en) * 2005-10-06 2010-10-13 Ntnu Technology Transfer As Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
US20080085295A1 (en) * 2006-07-14 2008-04-10 Fmc Biopolymer As Hydrogels containing low molecular weight alginates and biostructures made therefrom
GB0707096D0 (en) * 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
CN103463638A (zh) * 2007-08-28 2013-12-25 Fmc有限公司 延迟的自胶凝藻酸盐体系及其应用
CN101424535B (zh) * 2007-10-30 2012-05-30 武汉大学 多层道路中车辆定位方法及装置
JP5639475B2 (ja) 2007-11-27 2014-12-10 アルギファルマ アイピーアール エーエス バイオフィルムと闘う際のアルギネートオリゴマーの使用
EP2283146A4 (en) * 2008-04-29 2012-02-22 Marshall University Res Corp PROCESSES FOR PRODUCING BACTERIAL ALGINATES
JP2010187659A (ja) * 2009-01-20 2010-09-02 Kao Corp 精製アルギン酸又はその塩
GB0904942D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
GB0904941D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
CA2764195C (en) 2009-06-03 2017-09-26 Algipharma As Treatment of acinetobacter with alginate oligomers and antibiotics
GB0909529D0 (en) 2009-06-03 2009-07-15 Algipharma Ipr As Alginate oligomers for the inhibition of microbial adherence to surfaces
GB0909557D0 (en) 2009-06-03 2009-07-15 Algipharma Ipr As Anti-microbial alginate oligomers
CN101983974B (zh) * 2010-10-08 2014-07-16 青岛聚大洋海藻工业有限公司 食品添加剂g型褐藻胶提取及加工工艺
JP2012121963A (ja) * 2010-12-07 2012-06-28 Meiji Univ ポリグルロン酸の製造方法、ポリマンヌロン酸の製造方法、ポリグルロン酸、及びポリマンヌロン酸
CN102274447B (zh) * 2011-08-27 2013-01-02 赵国辉 一种用于治疗糖尿病的药物组合物
GB201116010D0 (en) 2011-09-15 2011-10-26 Algipharma As Use of alginate oligomers to enhance the effects of antifungal agents
TWI472536B (zh) 2013-05-14 2015-02-11 Hopewang Ent Co Ltd 含金屬晶體之海藻酸單體結構、含金屬晶體之海藻酸鹽單體結構、及含金屬晶體之海藻酸鹽凝膠結構與其製造方法
GB201322777D0 (en) 2013-12-20 2014-02-05 Algipharma As Use of alginate oligomers as blood anticoagulants
GB201415381D0 (en) 2014-08-29 2014-10-15 Algipharma As Inhalable powder formulations of alginate oligomers
GB201504878D0 (en) 2015-03-23 2015-05-06 Algipharma As Use of alginate oligomers and CFTR modulators in the treatment of conditions associated with CFTR dysfuntion
GB201517639D0 (en) 2015-10-06 2015-11-18 Algipharma As Use of alginate oligomers to treat or prevent microbial overgrowth in the intestinal tract
CN110198959B (zh) 2017-01-03 2023-03-28 北卡罗米纳大学查佩尔希尔分校 释放一氧化氮的海藻酸盐作为可生物降解抗菌支架和相关方法
JP7403152B2 (ja) 2017-03-28 2023-12-22 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 生分解可能な抗菌性スキャフォールドとしての一酸化窒素放出性ポリアミノグリコシドおよびそれに関する方法背景
CN107880150A (zh) * 2017-12-05 2018-04-06 四川大学 一种提高海藻酸盐中古洛糖醛酸单元含量的方法
EP3762039A4 (en) 2018-03-06 2021-12-22 The University of North Carolina at Chapel Hill NITRIC OXIDE RELEASING CYCLODEXTRINS AS BIODEGRADABLE ANTIBACTERIAL SCAFFOLDS AND RELATED PROCESSES
CN113383019B (zh) 2018-12-28 2023-11-17 北卡罗来纳大学教堂山分校 一氧化氮释放型抗菌聚合物和由其制成的支架和其相关方法
GB201908639D0 (en) 2019-06-17 2019-07-31 Algipharma Ipr As Use of alginate oligomers in the anticoagulation therapy of subjects at risk of blood clots which have an abnormally dense microstructure
GB202109772D0 (en) 2021-07-06 2021-08-18 Alginor Asa Method
WO2024141760A1 (en) 2022-12-30 2024-07-04 Algipharma As Compositions and methods to increase the systemic bioavailability of a polypeptide therapeutic agent undergoing oral administration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169840A (en) * 1991-03-27 1992-12-08 Nobipols Forskningsstiftelse Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation
US5503771A (en) * 1991-05-14 1996-04-02 Washington Technology Center Process for susupension of ceramic or metal particles using biologically produced polymers
RU2063754C1 (ru) * 1993-12-29 1996-07-20 Акционерное общество "Биотехнология" Ингибитор всасывания радионуклидов и усилитель элиминации их из организма
NO305441B1 (no) * 1996-07-12 1999-05-31 Norsk Hydro As Anvendelse av G-blokk polysakkarider

Also Published As

Publication number Publication date
WO1998051710A1 (en) 1998-11-19
DE69810609T2 (de) 2003-09-18
AU7457698A (en) 1998-12-08
US6121441A (en) 2000-09-19
NO305033B1 (no) 1999-03-22
CA2289710A1 (en) 1998-11-19
CA2289710C (en) 2006-11-21
CN1261375A (zh) 2000-07-26
NO972136L (no) 1998-11-10
NO972136D0 (no) 1997-05-09
CN1090193C (zh) 2002-09-04
JP4454700B2 (ja) 2010-04-21
JP2002504937A (ja) 2002-02-12
AU737398B2 (en) 2001-08-16
EP0980391A1 (en) 2000-02-23
ATE230763T1 (de) 2003-01-15
DE69810609D1 (de) 2003-02-13
EP0980391B1 (en) 2003-01-08

Similar Documents

Publication Publication Date Title
BR9809279A (pt) Procedimento para produção de uma fração de blocos g e/ou blocos m a partir de alginato
JO2359B1 (en) Benzathene derivatives as agents for modulation of GABA A receptor
BR9814611A (pt) Polipeptìdeos modificados dependentes de vitamina k
BG101892A (en) Sugar-modified cytostatics
GB0031527D0 (en) New use
WO1998058911A3 (en) Prostaglandin agonists
EP1978031A3 (en) Tropoelastin derivatives
BG105197A (en) Polymorph form of a medicament
CA2286296A1 (en) Inhibitors for urokinase receptor
BG103649A (en) Method for the preparation of eprosartan
BG102229A (en) Endothelium receptor antagonists
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES2177877T3 (es) Procedimiento para la fabricacion de 1,4-bis(aminometil)ciclohexano.
BG103650A (en) Method for the preparation of eprosartan
WO2001042250A3 (en) Process for production of diphenyl-dialkoxysilane, phenylalkyl-dialkoxysilane, octaphenylcyclotetrasiloxane and sym-tetraalkyltetraphenyl-cyclotetrasiloxane
ES2174150T3 (es) Procedimiento para la obtencion de 4-hidroxianilinas.
AU3189199A (en) Antisense modulation of lfa-3
YU62800A (sh) Postupak za proizvodnju r-(+)-6- karboksamido-3n-metilamino- 1,2,3,4-tetrahidrokarbazola
AU2910800A (en) Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
MY133085A (en) New 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1h-benz<f>indoles, processes for preparing them and their use as pharmaceutical compositions
ES2159742T3 (es) Procedimiento para la sintesis de benzo(b)tiofenos.
BG100779A (en) Derivatives of 12.13-epoxytylosin and methods for their preparation
AU4840496A (en) Modified guar, prepared by high shear treatment under acidic conditions at elevated temperature
GT199900057A (es) Procedimiento para la preparaciòn de ( s , s ) - bencil - 2,8 - diazabiciclo 4.3.0. nonano.
AU2024497A (en) Cycloalkyl derivatives and the solid-phase synthesis of such derivatives

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/05/1998, OBSERVADAS AS CONDICOES LEGAIS.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 08.05.2018